BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2015
View Archived Issues
Colonic release formulations of linaclotide under study in phase IIb trial
Read More
Amgen releases update from third quarter 2015
Read More
Highlights from ERS 2015
Read More
hVIVO invests in start-up company PrEP Biopharm
Read More
Sanofi profiles regulatory and development activities of third quarter 2015
Read More
Eisai reviews achievements of second quarter of fiscal 2015
Read More
Innate initiates phase I study of IPH-4102 in CTCL
Read More
NR-11/194: a potent CCR9 receptor antagonist
Read More
AS-002 shows preventative and curative effect in UC
Read More
ViiV Healthcare and Janssen report results from injectable cabotegravir regimen study
Read More
CJ Healthcare presents GPR40 agonists
Read More
Advances in siRNA therapeutic technology
Read More
OliX Pharmaceuticals discloses its cell-penetrating asymmetric siRNA technology
Read More
Tocopherol-conjugated DNA/RNA heteroduplex oligonucleotides enhance brain and liver targeting
Read More
BriaCell receives FDA approval to begin phase I/IIa trial of BriaVax
Read More
FDA grants orphan drug designation to AGIL-AS for Angelman syndrome
Read More
Institut Pasteur Korea and Terramark Markencreation disclose anti-HCV agents
Read More
Sunshine Lake Pharma patents 5-HT6 receptor antagonists
Read More
Takeda Pharmaceutical reports CDK8/19 inhibitors
Read More
Millennium Pharmaceuticals presents Nampt inhibitors
Read More
Ratiopharm introduces monomethyl fumarate prodrugs
Read More
Johnson & Johnson to acquire Novira Therapeutics
Read More
FDA grants fast track designation to long-acting buprenorphine for opioid addiction
Read More
FDA first to approve GlaxoSmithKline's Nucala
Read More
Phase II study of AQX-1125 in atopic dermatitis does not meet primary endpoint
Read More
Sanofi and Hanmi partner to develop long-acting diabetes treatments
Read More
FDA grants fast track designation to Paratek's omadacycline for ABSSSI, CABP and cUTI
Read More
Health Canada approves Cingal for osteoarthritis knee pain
Read More